Fosun Phama is working on launching ‘BNT162b2 in mainland China as soon as possible’, says Guo Guangchang, the billionaire chairman of majority shareholder Fosun International. Photo: AFP Fosun Phama is working on launching ‘BNT162b2 in mainland China as soon as possible’, says Guo Guangchang, the billionaire chairman of majority shareholder Fosun International. Photo: AFP
Fosun Phama is working on launching ‘BNT162b2 in mainland China as soon as possible’, says Guo Guangchang, the billionaire chairman of majority shareholder Fosun International. Photo: AFP

Coronavirus Hong Kong

Business

Fosun Pharma stock surges on prospect of Covid-19 vaccine launch in China, after German partner BioNTech’s clinical success

  • ‘A victory for science, a victory for global cooperation,’ says Guo Guangchang, the billionaire chairman of majority shareholder Fosun International
  • Fosun Pharma has a deal with Hong Kong-listed pharmaceutical distributor Jacobson Pharma for potentially supplying 10 million doses to Hong Kong and Macau

Topic |   Coronavirus Hong Kong
Eric Ng
Eric Ng

Updated: 8:55am, 11 Nov, 2020

Why you can trust SCMP
Fosun Phama is working on launching ‘BNT162b2 in mainland China as soon as possible’, says Guo Guangchang, the billionaire chairman of majority shareholder Fosun International. Photo: AFP Fosun Phama is working on launching ‘BNT162b2 in mainland China as soon as possible’, says Guo Guangchang, the billionaire chairman of majority shareholder Fosun International. Photo: AFP
Fosun Phama is working on launching ‘BNT162b2 in mainland China as soon as possible’, says Guo Guangchang, the billionaire chairman of majority shareholder Fosun International. Photo: AFP
READ FULL ARTICLE